Lumenis Ltd. is a provider of energy-based, minimally invasive clinical solutions. The Company operated in three segments: surgical, ophthalmic and aesthetic. It provides energy-based solutions for both medically necessary and elective procedures, primarily for the aging population. Its focused product offerings provide solutions for a range of minimally invasive procedures. Its solutions include its VersaPulse PowerSuite platform using high-powered holmium lasers for urologic applications, its M22 multi-energy, multi-application platform for the treatment of various skin conditions, and its Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. Its primary target markets for its products are hospitals, outpatient clinics, ambulatory surgery centers, physicians’ offices, private clinics and aesthetic chains.
Address
6 Hakidma Street Yokneam Industrial Park, P.O.B. 240
YOKNEAM, 2069204
Israel
YOKNEAM, 2069204
Israel
Website links
http://www.lumenis.comKey stats and ratios
| Q4 (Dec '13) | 2013 | |
| Net profit margin | 6.61% | 6.55% |
| Operating margin | 8.86% | 9.65% |
| EBITD margin | - | 9.36% |
| Return on average assets | 9.31% | 8.88% |
| Return on average equity | 123.60% | 198.75% |
| Employees | 1,061 |
No comments:
Post a Comment